EBOS Group Limited

EBOSY

OTC

41.94

USD

0.00(0.00%)

As of today

Overview Financials Dividends Ratios Discussions Analysis

EBOS Group Limited fundamentals

Overview Income Statement Balance Sheet Cash Flow

Key ratios

P/E Ratio

22.92

Price/Book

0.70

Debt/Equity

59.20%

Return on Equity

6.22%

Dividend Yield

2.69%

EBITDA

579.91M

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Statements Highlights

AnnualQuarterly

Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025
Total Revenue	9,888,134,000	11,901,673,000	13,317,446,000	14,411,117,000	13,208,676,644
Gross Profit	1,066,337,000	1,380,713,000	1,698,915,000	1,784,207,000	1,762,864,218
Operating Income	317,526,000	250,728,000	498,997,000	527,244,000	455,580,919
Net Income	199,094,000	224,642,000	275,735,000	296,710,000	231,655,000
Total Assets	4,243,857,311	6,945,941,900	7,005,150,723	7,368,948,863	7,837,024,873
Total Current Liabilities	2,017,813,473	1,729,919,729	2,892,646,642	3,413,894,230	2,815,675,675
Total Equity	1,510,371,763	2,385,581,550	2,506,649,254	2,642,590,690	2,932,946,053
Free Cash Flow	232,141,398	176,407,583	318,885,624	288,175,262	396,379,885
Cash from Operations	222,525,718	180,381,146	263,258,225	228,194,837	450,633,143
Cash from Investing	-122,233,802.514	-1,548,061,869.387	-167,880,074.002	-413,157,779.72	-397,168,084
Cash from Financing	-279,333,834.748	1,664,952,877	-595,419,523.343	37,509,833	-91,413,804
Net Change in Cash	-81,470,935.855	386,254,573	-332,386,549.135	5,460,008	-35,137,288